Key use cases for artificial intelligence to reduce the frequency of adverse drug events: a scoping review

Key use cases for artificial intelligence to reduce the frequency of adverse drug events: a scoping review

Summary: Adverse drug events (ADEs) represent one of the most prevalent types of health-care-related harm, and there is substantial room for improvement in the way that they are currently predicted and detected. We conducted a scoping review to identify key use cases in which artificial intelligence...

Full description

Bibliographic Details
Main Authors: Ania Syrowatka, PhD, Wenyu Song, PhD, Mary G Amato, PharmD, Dinah Foer, MD, Heba Edrees, PharmD, Zoe Co, BS, Masha Kuznetsova, MPH, Sevan Dulgarian, BS, Diane L Seger, RPh, Aurélien Simona, MD, Paul A Bain, PhD, Gretchen Purcell Jackson, MD, Kyu Rhee, MD, David W Bates, ProfMD
Format: Article
Language:English
Published: Elsevier 2022-02-01
Series:The Lancet: Digital Health
Online Access:http://www.sciencedirect.com/science/article/pii/S2589750021002296

Internet

http://www.sciencedirect.com/science/article/pii/S2589750021002296

Similar Items